0001745285-20-000015.txt : 20200617 0001745285-20-000015.hdr.sgml : 20200617 20200617172636 ACCESSION NUMBER: 0001745285-20-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200616 FILED AS OF DATE: 20200617 DATE AS OF CHANGE: 20200617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Corvese Brian CENTRAL INDEX KEY: 0001393207 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 20970624 MAIL ADDRESS: STREET 1: C/O ANTIGENICS INC. STREET 2: 162 FIFTH AVENUE, SUITE 900 CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-06-16 0 0001098972 AGENUS INC AGEN 0001393207 Corvese Brian C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421 1 0 0 0 Restricted Stock Unit 2020-06-16 4 A 0 22471 0 A 2021-06-16 Common Stock 22471 49589 D Stock Option (Right to buy) 3.56 2020-06-16 4 A 0 2500 0 A 2021-06-16 2030-06-16 Common Stock 2500 2500 D (1) Restricted Stock Unit was granted on June 16, 2020 in accordance with the Agenus Inc. 2019 Equity Incentive Plan. The award vests in full on June 16, 2021. Includes 27,118 Restricted Stock Units that are scheduled to vest on June 19, 2020. Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan and will vest on June 16, 2021. /s/Evan D. Kearns, as Attorney-in-Fact for Brian Corvese 2020-06-17